Bacterial, viral, parasitic, and mycoplasmal antigens and their toxins

Bacterial, viral, parasitic, and mycoplasmal antigens and their toxins represent a broad category of pathogen-derived molecules that serve as the primary targets for the host immune system and medical interventions. These entities include structural components such as viral envelope glycoproteins (e.g., the SARS-CoV-2 Spike protein), bacterial cell wall elements like lipopolysaccharides, and secreted virulence factors known as exotoxins (e.g., Botulinum or Tetanus toxins) (NIAID, 2023; StatPearls, 2023). In pharmacology, these molecules are the fundamental components of vaccines, which prime the immune system to recognize and neutralize pathogens upon future exposure. Additionally, monoclonal antibodies and antitoxins are specifically engineered to bind these antigens or toxins to provide passive immunity or to neutralize harmful biochemical effects during an active infection (PubMed, 2022). Because this entry describes a diverse group of biological products rather than a single molecular target, it is typically used as a classification for immunologics and diagnostic reagents. Understanding the molecular diversity and variability of these antigens is critical for addressing challenges such as antigenic variation and ensuring the broad efficacy of anti-infective therapies.

Other names

Microbial antigensPathogen-derived antigensExotoxinsEndotoxinsToxoidsInfectious agent antigensPathogen-associated molecular patterns (PAMPs)

Drugs targeting these entities primarily function through neutralization, where antibodies bind to the antigen or toxin to prevent its interaction with host cell receptors, or through active immunization, where the antigen is introduced to stimulate the host's adaptive immune system to produce endogenous antibodies and memory cells (CDC, 2023; WHO, 2022).